Herbalife Ltd. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Shareholders' (Deficit) Equity

Consolidated Statements of Changes in Shareholders' (Deficit) Equity (USD $) In Millions	Total	Common Shares [Member]	Paid-in Capital in Excess of par Value [Member]	Accumulated Other Comprehensive Loss [Member]	(Accumulated Deficit) Retained Earnings [Member]
Beginning Balance at Dec. 31, 2011	$ 548.2us-gaap_StockholdersEquity	$ 0.1	$ 292.0	$ (37.8)	$ 293.9
Issuance of 2.1 million, 0.4 million and 1.4 million common shares from exercise of stock options, SARs, restricted stock units, employee stock purchase plan, in 2012, 2013 and 2014 respectively and 0.4 million from exercise of warrants in 2012, respectively	11.3		11.3
Excess tax benefit from exercise of stock options, SARs and restricted stock grants	29.7		29.7
Additional capital from share based compensation	28.1		28.1
Repurchases of 11.5 million, 6.2 million and 20.2 million common shares, inclusive of the Forward Transactions in 2012, 2013 and 2014 respectively	(556.8)		(57.7)		(499.1)
Dividends and dividend equivalents ($1.20 per share, $1.20 per share and $0.30 per share) in 2012, 2013 and 2014 respectively	(135.1)us-gaap_DividendsCommonStockCash		0.6		(135.7)
Net income	464.0us-gaap_NetIncomeLoss				464.0
Foreign currency translation adjustment, net of income taxes of $0.3, $(4.3) and $(7.3) in 2012, 2013 and 2014 respectively	9.8			9.8
Unrealized gain (loss) on derivatives, net of income taxes of ($1.2), $1.7 and $0.6 in 2012, 2013 and 2014 respectively	(3.7)			(3.7)
Ending Balance at Dec. 31, 2012	395.5us-gaap_StockholdersEquity	0.1	304.0	(31.7)	123.1
Issuance of 2.1 million, 0.4 million and 1.4 million common shares from exercise of stock options, SARs, restricted stock units, employee stock purchase plan, in 2012, 2013 and 2014 respectively and 0.4 million from exercise of warrants in 2012, respectively	1.0		1.0
Excess tax benefit from exercise of stock options, SARs and restricted stock grants	15.6		15.6
Additional capital from share based compensation	29.5		29.5
Repurchases of 11.5 million, 6.2 million and 20.2 million common shares, inclusive of the Forward Transactions in 2012, 2013 and 2014 respectively	(306.5)		(26.6)		(279.9)
Dividends and dividend equivalents ($1.20 per share, $1.20 per share and $0.30 per share) in 2012, 2013 and 2014 respectively	(123.1)us-gaap_DividendsCommonStockCash		0.4		(123.5)
Net income	527.5us-gaap_NetIncomeLoss				527.5
Foreign currency translation adjustment, net of income taxes of $0.3, $(4.3) and $(7.3) in 2012, 2013 and 2014 respectively	3.2			3.2
Unrealized gain (loss) on derivatives, net of income taxes of ($1.2), $1.7 and $0.6 in 2012, 2013 and 2014 respectively	8.6			8.6
Unrealized gain on available-for-sale investments, net of income taxes of $0.1 and $0.1 in 2013 and 2014 respectively	0.1			0.1
Ending Balance at Dec. 31, 2013	551.4us-gaap_StockholdersEquity	0.1	323.9	(19.8)	247.2
Issuance of 2.1 million, 0.4 million and 1.4 million common shares from exercise of stock options, SARs, restricted stock units, employee stock purchase plan, in 2012, 2013 and 2014 respectively and 0.4 million from exercise of warrants in 2012, respectively	0.7		0.7
Excess tax benefit from exercise of stock options, SARs and restricted stock grants	10.4		10.4
Additional capital from share based compensation	45.7		45.7
Repurchases of 11.5 million, 6.2 million and 20.2 million common shares, inclusive of the Forward Transactions in 2012, 2013 and 2014 respectively	(1,291.9)		(97.6)		(1,194.3)
Dividends and dividend equivalents ($1.20 per share, $1.20 per share and $0.30 per share) in 2012, 2013 and 2014 respectively	(30.4)us-gaap_DividendsCommonStockCash				(30.4)
Dividends received	3.4us-gaap_DividendIncomeOperating				3.4
Issuance of the convertible notes and forward transaction	249.8		249.8
Payments for capped call transactions	(123.8)hlf_CappedCallTransactions		(123.8)
Net income	308.7us-gaap_NetIncomeLoss				308.7
Foreign currency translation adjustment, net of income taxes of $0.3, $(4.3) and $(7.3) in 2012, 2013 and 2014 respectively	(70.8)			(70.8)
Unrealized gain (loss) on derivatives, net of income taxes of ($1.2), $1.7 and $0.6 in 2012, 2013 and 2014 respectively	12.3			12.3
Unrealized gain on available-for-sale investments, net of income taxes of $0.1 and $0.1 in 2013 and 2014 respectively	0.1			0.1
Ending Balance at Dec. 31, 2014	$ (334.4)us-gaap_StockholdersEquity	$ 0.1	$ 409.1	$ (78.2)	$ (665.4)